Follow
John Duley
John Duley
Verified email at pharmacy.uq.edu.au
Title
Cited by
Cited by
Year
Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase)
AM Marinaki, A Ansari, JA Duley, M Arenas, S Sumi, CM Lewis, ...
Pharmacogenetics and Genomics 14 (3), 181-187, 2004
3782004
Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease
A Ansari, C Hassan, J Duley, A Marinaki, EM Shobowale‐Bakre, P Seed, ...
Alimentary pharmacology & therapeutics 16 (10), 1743-1750, 2002
3042002
Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency
S Sumi, AM Marinaki, M Arenas, L Fairbanks, M Shobowale-Bakre, ...
Human genetics 111, 360-367, 2002
2992002
Uridine and its nucleotides: biological actions, therapeutic potentials
GP Connolly, JA Duley
Trends in pharmacological sciences 20 (5), 218-225, 1999
2461999
Prospective evaluation of the pharmacogenetics of azathioprine in the treatment of inflammatory bowel disease
A Ansari, M Arenas, SM Greenfield, D Morris, J Lindsay, K Gilshenan, ...
Alimentary pharmacology & therapeutics 28 (8), 973-983, 2008
2132008
THE IMPORTANCE OF THIOPURINE METHYLTRANSFERASE ACTIVITY FOR THE USE OF AZATHIOPRINE IN TRANSPLANT RECIPIENTS1
PR Chocair, JA Duley, HA Simmonds, JS Cameron
Transplantation 53 (5), 1051-1055, 1992
2001992
Thiopurine methyltransferase: should it be measured before commencing thiopurine drug therapy?
J Sanderson, A Ansari, T Marinaki, J Duley
Annals of clinical biochemistry 41 (4), 294-302, 2004
1652004
An international classification of inherited metabolic disorders (ICIMD)
CR Ferreira, S Rahman, M Keller, J Zschocke, ICIMD Advisory Group, ...
Journal of inherited metabolic disease 44 (1), 164-177, 2021
1612021
Low‐dose azathioprine or mercaptopurine in combination with allopurinol can bypass many adverse drug reactions in patients with inflammatory bowel disease
A Ansari, N Patel, J Sanderson, J O’donohue, JA Duley, THJ Florin
Alimentary pharmacology & therapeutics 31 (6), 640-647, 2010
1602010
Long‐term outcome of using allopurinol co‐therapy as a strategy for overcoming thiopurine hepatotoxicity in treating inflammatory bowel disease
A Ansari, T Elliott, B Baburajan, P Mayhead, J O’donohue, P Chocair, ...
Alimentary pharmacology & therapeutics 28 (6), 734-741, 2008
1462008
Nomenclature for alleles of the thiopurine methyltransferase gene
ML Appell, J Berg, J Duley, WE Evans, MA Kennedy, L Lennard, ...
Pharmacogenetics and genomics 23 (4), 242-248, 2013
1402013
Novel disease-causing mutations in the dihydropyrimidine dehydrogenase gene interpreted by analysis of the three-dimensional protein structure
ABP van KUILENBURG, D Dobritzsch, R Meinsma, J Haasjes, ...
Biochemical journal 364 (1), 157-163, 2002
1392002
Azathioprine intolerance in patients with IBD may be imidazole-related and is independent of TPMT activity
DPB McGovern, SPL Travis, J Duley, EM Shobowale-Bakre, HR Dalton
Gastroenterology 122 (3), 838-839, 2002
1362002
Analysis of purines and pyrimidines in blood, urine and other physiological fluids
HA Simmonds, JA Duley, PM Davies
Techniques in diagnostic human biochemical genetics: a laboratory manual …, 1991
1361991
PRPS1 mutations: four distinct syndromes and potential treatment
APM de Brouwer, H van Bokhoven, SB Nabuurs, WF Arts, J Christodoulou, ...
The American Journal of Human Genetics 86 (4), 506-518, 2010
1312010
Thiopurine therapies: problems, complexities, and progress with monitoring thioguanine nucleotides
JA Duley, THJ Florin
Therapeutic drug monitoring 27 (5), 647-654, 2005
1222005
Analysis of human alcohol‐and aldehyde‐metabolizing isozymes by electrophoresis and isoelectric focusing
JA Duley, O Harris, RS Holmes
Alcoholism: Clinical and Experimental Research 9 (3), 263-271, 1985
1191985
Breastmilk-saliva interactions boost innate immunity by regulating the oral microbiome in early infancy
SS Al-Shehri, CL Knox, HG Liley, DM Cowley, JR Wright, MG Henman, ...
PloS one 10 (9), e0135047, 2015
1182015
Erythrocyte thiopurine methyl transferase assessment prior to azathioprine use in the UK
SA Holme, JA Duley, J Sanderson, PA Routledge, AV Anstey
Qjm 95 (7), 439-444, 2002
1092002
Novel pharmacogenetic markers for treatment outcome in azathioprine‐treated inflammatory bowel disease
MA Smith, AM Marinaki, M Arenas, M Shobowale‐Bakre, CM Lewis, ...
Alimentary pharmacology & therapeutics 30 (4), 375-384, 2009
1042009
The system can't perform the operation now. Try again later.
Articles 1–20